Skin aspects of COVID-19
DOI:
https://doi.org/10.20883/medical.e1023Keywords:
blood coagulation, COVID-19 skin lesions, SARS-CoV-2, critical care, dermatological manifestationsAbstract
Background: COVID-19 is a disease that has changed the realities of society, medical personnel, and patients around the world. The long-term course of the COVID-19 pandemic has allowed us to observe the many changes that are occurring in the course of this disease. Lesions resulting from SARS-CoV-2 infection manifest not only in the lungs but also in other systems, including the skin.
Methods: The paper presents a comprehensive description of skin lesions occurring in the course of COVID-19 based on a literature review and own experience acquired in the intensive care unit.
Results: The mechanism of formation of the cutaneous manifestations in SARS-CoV-2 infected patients as a result of the course of the disease was discussed. Skin lesions from the treatment, hospitalization and immobilization of the patient were also considered.
The causes of developing bedsores are also highlighted, with examples provided with photographs. In addition, the paper includes tables comparing the appearance of skin lesions with the severity of the course and caused by pharmacotherapy, which may be a practical instrument in clinical practice.
Conclusions: Cutaneous manifestations may be the single symptom of COVID-19, which may facilitate the diagnosis of this disease. It seems necessary to extend the diagnostics of skin lesions in the course of COVID-19 in order to understand their pathogenesis. Inadequate care due to staff shortages or inadequate education may lead to the development of pressure sores. It would seem imperative to implement solutions that could protect both patients and staff in the event of future pandemics.
Downloads
References
Gawaz A, Guenova E. Microvascular Skin Manifestations Caused by COVID-19. Hamostaseologie. październik 2021;41(5):387–96.
Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 18 czerwiec 2020;24(1):360.
Magadum A, Kishore R. Cardiovascular Manifestations of COVID-19 Infection. Cells. 19 listopad 2020;9(11):2508.
Verdecchia P, Cavallini C, Spanevello A, Angeli F. COVID-19: ACE2centric Infective Disease? Hypertension. sierpień 2020;76(2):294–9.
Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci. lipiec 2015;1347:45–51.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, i in. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2 maj 2020;395(10234):1417–8.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, i in. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 28 marzec 2020;395(10229):1054–62.
Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J xing, i in. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 28 luty 2020;NEJMoa2002032.
Connors JM, Brooks MM, Sciurba FC, Krishnan JA, Bledsoe JR, Kindzelski A, i in. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial. JAMA. 2 listopad 2021;326(17):1703–12.
The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome - Ranucci - 2020 - Journal of Thrombosis and Haemostasis - Wiley Online Library [Internet]. [cytowane 2 maj 2023]. Dostępne na: https://onlinelibrary.wiley.com/doi/full/10.1111/jth.14854
Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, i in. Clinical features and treatment of COVID‐19 patients in northeast Chongqing. J Med Virol. lipiec 2020;92(7):797–806.
Akca S, Haji-Michael P, de Mendonça A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med. kwiecień 2002;30(4):753–6.
McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, i in. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy. J Hepatol. wrzesień 2021;75(3):647–58.
Smadja DM, Guerin CL, Chocron R, Yatim N, Boussier J, Gendron N, i in. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. listopad 2020;23(4):611–20.
Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, i in. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–98.
Escher R, Breakey N, Lämmle B. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients. Thromb Res. sierpień 2020;192:174–5.
Martin FA, Murphy RP, Cummins PM. Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects. Am J Physiol Heart Circ Physiol. 15 czerwiec 2013;304(12):H1585–97.
Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, i in. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. The Lancet Haematology. 1 sierpień 2020;7(8):e575–82.
Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. lipiec 2020;506:145–8.
Alramthan A, Aldaraji W. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East. Clin Exp Dermatol. sierpień 2020;45(6):746–8.
Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. czerwiec 2020;34(6):e246–7.
Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, i in. The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. październik 2020;83(4):1118–29.
Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, i in. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. lipiec 2020;183(1):71–7.
Nakashima C, Kato M, Otsuka A. Cutaneous manifestations of COVID-19 and COVID-19 vaccination. The Journal of Dermatology. 2023;50(3):280–9.
Young S, Fernandez AP. Skin manifestations of COVID-19. CCJM [Internet]. 14 maj 2020 [cytowane 2 maj 2023]; Dostępne na: https://www.ccjm.org/content/early/2020/05/12/ccjm.87a.ccc031
Novak N, Peng W, Naegeli MC, Galvan C, Kolm-Djamei I, Brüggen C, i in. SARS-CoV-2, COVID-19, skin and immunology - What do we know so far? Allergy. marzec 2021;76(3):698–713.
Toader MP, Branisteanu DC, Glod M, Esanu IM, Branisteanu CI, Capsa MS, i in. Mucocutaneous lesions associated with SARS-CoV-2 infection (Review). Exp Ther Med. kwiecień 2022;23(4):258.
GÜL Ü. COVID-19 and dermatology. Turk J Med Sci. 17 grudzień 2020;50(8):1751–9.
Massey PR, Jones KM. Going viral: A brief history of Chilblain-like skin lesions (“COVID toes”) amidst the COVID-19 pandemic. Semin Oncol. październik 2020;47(5):330–4.
Ladha MA, Dupuis EC. SARS-CoV-2-related chilblains. CMAJ. 13 lipiec 2020;192(28):E804.
Stadnytskyi V, Bax CE, Bax A, Anfinrud P. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proceedings of the National Academy of Sciences. 2 czerwiec 2020;117(22):11875–7.
Daneshgaran G, Dubin DP, Gould DJ. Cutaneous Manifestations of COVID-19: An Evidence-Based Review. Am J Clin Dermatol. październik 2020;21(5):627–39.
Diotallevi F, Campanati A, Bianchelli T, Bobyr I, Luchetti MM, Marconi B, i in. Skin involvement in SARS-CoV-2 infection: Case series. J Med Virol. listopad 2020;92(11):2332–4.
Kaya G, Kaya A, Saurat JH. Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature. Dermatopathology (Basel). 30 czerwiec 2020;7(1):3–16.
Panahi A, Couch KS, White PB, Chao JW. Acute Skin Failure Associated with Severe COVID-19. Plast Reconstr Surg. styczeń 2023;151(1):185–6.
Walecka-Herniczek I. Skin lesions in the course of COVID-19 [Zmiany skórne w przebiegu COVID-19]T. W Warszawa/online: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. prof. dr hab. med. Eleonory Reicher; 2021. s. 43–5.
Hernández N, Sanclemente G, Tamayo L, López Á, Seidel A. Atopic dermatitis in the COVID-19 era: Results from a web-based survey. World Allergy Organ J. 24 sierpień 2021;14(8):100571.
Magierska A, Ptak O, Szczepaniak Z, Gomułka K. Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease. Postepy Dermatol Alergol. październik 2022;39(5):998–1000.
Türsen Ü, Türsen B, Lotti T. Cutaneous sıde-effects of the potential COVID-19 drugs. Dermatol Ther. lipiec 2020;33(4):e13476.
Martinez-Lopez A, Cuenca-Barrales C, Montero-Vilchez T, Molina-Leyva A, Arias-Santiago S. Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist. J Am Acad Dermatol. grudzień 2020;83(6):1738–48.
Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, i in. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther. kwiecień 2021;35(2):215–29.
Ridolo E, Pucciarini F, Barone A, Nouvenne A, Meschi T, Peveri S, i in. Dermatological manifestations during COVID-19 infection: a case series and discussion on the problem of differential diagnosis. Acta Biomed. 2021;92(1):e2021103.
Enoxaparin sodium/methylprednisolone/remdesivir. Reactions Weekly. 2021;1852(1):179.
Sotrovimab dosing, indications, interactions, adverse effects, and more [Internet]. [cytowane 2 maj 2023]. Dostępne na: https://reference.medscape.com/drug/sotrovimab-4000220
Martora F, Battista T, Ruggiero A, Scalvenzi M, Villani A, Megna M, i in. The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature. Viruses. 23 czerwiec 2023;15(7):1423.
Sekizawa A, Hashimoto K, Kobayashi S, Kozono S, Kobayashi T, Kawamura Y, i in. Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report. Front Med [Internet]. 1 sierpień 2022 [cytowane 15 czerwiec 2024];9. Dostępne na: https://www.frontiersin.org/articles/10.3389/fmed.2022.963393
Han TY, Shim DH, Lee YJ, Lee YB, Koo HYR, Shin MK, i in. Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study. Ann Dermatol. luty 2023;35(1):38–45.
Bourkas AN, Zaman M, Sibbald RG. COVID-19 and Hospital-Acquired Pressure Injuries: A Systematic Review. Adv Skin Wound Care. 27 styczeń 2023;
Sianes-Gallén M, Pujol-García AM, Rus García M, Partera Luque C, López Postigo M, Call Mañosa S, i in. Pressure injuries during the SARS-CoV-2 pandemic: A retrospective, case-control study. J Tissue Viability. listopad 2021;30(4):478–83.
Modeling Patient Risk for Hospital-Acquired Pressure Injuries During COVID-19 - PMC [Internet]. [cytowane 3 maj 2023]. Dostępne na: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860131/
Wounds UK- Issue: 13-09-2021, Vol 17, No 3 - article: Medical device-related pressure ulcers and the COVID-19 pandemic: from aetiology to prevention - Wounds UK [Internet]. [cytowane 3 maj 2023]. Dostępne na: https://www.wounds-uk.com/journals/issue/651/article-details/medical-device-related-pressure-ulcers-and-the-covid-19-pandemic-from-aetiology-to-prevention
Gefen A, Ousey K. COVID-19: pressure ulcers, pain and the cytokine storm. J Wound Care. 2 październik 2020;29(10):540–2.
Keller KG, Reangsing C, Schneider JK. Clinical presentation and outcomes of hospitalized adults with COVID-19: A systematic review. J Adv Nurs. grudzień 2020;76(12):3235–57.
Kang ZQ, Zhai XJ. The Association between Pre-existing Diabetes Mellitus and Pressure Ulcers in Patients Following Surgery: A Meta-analysis. Sci Rep. 11 sierpień 2015;5:13007.
Wang Y, Chen R, Ding J, Yang L, Chen J, Huang B. Predictive value of pressure ulcer risk for obstructive coronary artery disease. Nurs Open. lipiec 2021;8(4):1848–55.
Rezaei N, Montazeri F, Malekpour MR, Ghanbari A, Azadnajafabad S, Mohammadi E, i in. COVID-19 in patients with diabetes: factors associated with worse outcomes. J Diabetes Metab Disord. grudzień 2021;20(2):1605–14.
Liang C, Zhang W, Li S, Qin G. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Barc). 11 czerwiec 2021;156(11):547–54.
Martel T, Orgill DP. Medical Device–Related Pressure Injuries During the COVID-19 Pandemic. J Wound Ostomy Continence Nurs. wrzesień 2020;47(5):430–4.
The national cost of hospital‐acquired pressure injuries in the United States - PMC [Internet]. [cytowane 3 maj 2023]. Dostępne na: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948545/
Team V, Team L, Jones A, Teede H, Weller CD. Pressure Injury Prevention in COVID-19 Patients With Acute Respiratory Distress Syndrome. Front Med (Lausanne). 22 styczeń 2021;7:558696.
Parisod H, Holopainen A, Koivunen M, Puukka P, Haavisto E. Factors determining nurses’ knowledge of evidence-based pressure ulcer prevention practices in Finland: a correlational cross-sectional study. Scand J Caring Sci. marzec 2022;36(1):150–61.
Gasparino RC, Lima MHM, de Souza Oliveira-Kumakura AR, da Silva VA, de Jesus Meszaros M, Antunes IR. Prophylactic dressings in the prevention of pressure ulcer related to the use of personal protective equipment by health professionals facing the COVID-19 pandemic: A randomized clinical trial. Wound Repair Regen. styczeń 2021;29(1):183–8.
Zwitterionic Hydrogel Activates Autophagy to Promote Extracellular Matrix Remodeling for Improved Pressure Ulcer Healing - PubMed [Internet]. [cytowane 3 maj 2023]. Dostępne na: https://pubmed.ncbi.nlm.nih.gov/34692658/
Negri EM, Piloto BM, Morinaga LK, Jardim CVP, Lamy SAED, Ferreira MA, i in. Heparin Therapy Improving Hypoxia in COVID-19 Patients - A Case Series. Front Physiol. 2020;11:573044.
Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, i in. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19. JAMA Intern Med. grudzień 2021;181(12):1612–20.
Schols RM, de Henau M, Colla C, van den Kerckhove E, Tuinder SMH, van der Hulst RRWJ, i in. Facial Scars Due to Prone Position Pressure Ulcers: Underestimated Sequelae in COVID-19 Survivors? Aesthet Surg J. 12 czerwiec 2021;41(11):NP1812–3.
Bain M, Hara J, Carter MJ. The Pathophysiology of Skin Failure vs. Pressure Injury: Conditions That Cause Integument Destruction and Their Associated Implications. Wounds. listopad 2020;32(11):319–27.
Elizabeth Foy White-Chu M 1, Diane Langemo P. Skin Failure: Identifying and Managing an Underrecognized Condition. Annals of Long-Term Care [Internet]. 19 lipiec 2012 [cytowane 2 maj 2023];20(7). Dostępne na: https://www.hmpgloballearningnetwork.com/site/altc/articles/skin-failure-identifying-and-managing-underrecognized-condition
García-Fernández FP, Soldevilla-Agreda JJ, Rodriguez-Palma M, Pancorbo-Hidalgo PL. Skin injuries associated with severe life-threatening situations: A new conceptual framework. J Nurs Scholarsh. styczeń 2022;54(1):72–80.
Greenway A, Leahy N, Torrieri L, An A, Fink SA, Witenko C, i in. Skin Failure Among Critically Ill Patients Afflicted with Coronavirus Disease 2019 (COVID-19). J Intensive Care Med. listopad 2021;36(11):1331–9.
Wong K, Farooq Alam Shah MU, Khurshid M, Ullah I, Tahir MJ, Yousaf Z. COVID-19 associated vasculitis: A systematic review of case reports and case series. Ann Med Surg (Lond). 13 styczeń 2022;74:103249.
Badia M, Casanova JM, Serviá L, Montserrat N, Codina J, Trujillano J. Dermatological Manifestations in the Intensive Care Unit: A Practical Approach. Crit Care Res Pract. 26 wrzesień 2020;2020:9729814.
Capoferri G, Daikeler T, Mühleisen B, Trendelenburg M, Müller S. Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis. Clin Dermatol. 2022;40(4):397–401.
Laurence J, Nuovo G, Racine-Brzostek SE, Seshadri M, Elhadad S, Crowson AN, i in. Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage. Am J Pathol. wrzesień 2022;192(9):1282–94.
Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. wrzesień 2020;183(3):431–42.
Stone KW, Kintziger KW, Jagger MA, Horney JA. Public Health Workforce Burnout in the COVID-19 Response in the U.S. International Journal of Environmental Research and Public Health [Internet]. kwiecień 2021 [cytowane 2 maj 2023];18(8). Dostępne na: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074254/
Golinowska S, Zabdyr-Jamróz M, Magnavita N, Scheres J, Nartowski R, Tomczak DA, i in. Public Governance of the Health Crisis in the First Six Months of the Global COVID-19 Pandemic. Comparative Analysis Based on the Opinions of Experts from Selected Countries. Zdrowie Publiczne i Zarządzanie. 2020;18(nr 1):1–31.
Gajda K, Kózka M, Brzyski P, Gabryś T, Przewoźniak L, Cisek M, i in. Influence of hospital staffing and selected organisational circumstances on the death rate of patients treated in Polish hospitals participating in the RN4CAST project [Wpływ struktury zatrudnienia personelu i wybranych czynników organizacyjnych szpitala na wskaźnik zgonów pacjentów hospitalizowanych w szpitalach polskich uczestniczących w projekcie RN4CAST]. Zdrowie Publiczne i Zarządzanie [Internet]. 2012 [cytowane 5 maj 2023];10(4). Dostępne na: http://cejsh.icm.edu.pl/cejsh/element/bwmeta1.element.ojs-issn-2084-2627-year-2012-volume-10-issue-4-article-2859
Tańska E. Logistics and organizational challenges in an oncology institution during the COVID-19 pandemic. 17 grudzień 2021;
Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Management of antiphospholipid syndrome. Ann Rheum Dis. luty 2019;78(2):155–61.
Lenormand C, Lipsker D. Lupus erythematosus: Significance of dermatologic findings. Ann Dermatol Venereol. marzec 2021;148(1):6–15.
Velter C, Lipsker D. [Cutaneous panniculitis]. Rev Med Interne. listopad 2016;37(11):743–50.
Saadoun D, Musset L, Cacoub P. [Cryofibrinogenemia]. Rev Med Interne. maj 2011;32(5):287–91.
Long WB, Edlich RF, Winters KL, Britt LD. Cold injuries. J Long Term Eff Med Implants. 2005;15(1):67–78.
Aringer M, Günther C, Lee-Kirsch MA. Innate immune processes in lupus erythematosus. Clin Immunol. czerwiec 2013;147(3):216–22.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 The copyright to the submitted manuscript is held by the Author, who grants the Journal of Medical Science (JMS) a nonexclusive licence to use, reproduce, and distribute the work, including for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Accepted 2024-07-09
Published 2024-09-30
